Mekanistic Therapeutics

About:

Mekanistic Therapeutics is a drug designer for cancer.

Description:

Mekanistic is a biotechnology company that is redefining oncology. They offer a novel class of selective kinase inhibitors that are rationally designed to target EGFR and PI3K with a single molecule. They use computational tools and also design medications that perfectly fit within those sites to inhibit the spread of cancer.

Total Funding Amount:

$30M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Ann Arbor, Michigan, United States

Founded Date:

2022-01-01

Contact Email:

info(AT)mekanistictherapeutics.com

Founders:

Judy Sebolt-Leopold

Number of Employees:

1-10

Last Funding Date:

2022-06-14

IPO Status:

Private

Industries: